Diaceutics PLC (AIM:DXRX)

London flag London · Delayed Price · Currency is GBP · Price in GBX
137.00
+1.50 (1.11%)
At close: Dec 5, 2025
17.60%
Market Cap 115.95M
Revenue (ttm) 34.40M
Net Income (ttm) -1.52M
Shares Out 84.64M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE 52.69
Dividend n/a
Ex-Dividend Date n/a
Volume 157,122
Average Volume 88,668
Open 135.50
Previous Close 135.50
Day's Range 135.00 - 139.00
52-Week Range 106.00 - 168.00
Beta 0.95
RSI 14.93
Earnings Date Dec 24, 2025

About Diaceutics

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using... [Read more]

Industry Medical - Diagnostics & Research
Sector Healthcare
Founded 2005
Employees 199
Stock Exchange London Stock Exchange AIM
Ticker Symbol DXRX
Full Company Profile

Financial Performance

In 2024, Diaceutics's revenue was 32.16 million, an increase of 35.69% compared to the previous year's 23.70 million. Losses were -1.70 million, -2.46% less than in 2023.

Financial Statements

News

There is no news available yet.